Insider Cluster (2 insiders) ·Filed Aug 18, 2026

IRON

Disc Medicine, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $723K total
Actionable Insight • Neutral

The CEO's sales are routine post-exercise dispositions with no bearish signal. Monitor next quarterly filing for pipeline updates on bitopertin and DISC-0974, which are the primary catalysts for IRON's valuation. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
IRON ▼ -13.87% at T+20d
NEUTRAL call ✗ call lost -13.87% · α vs SPY -11.92% · entry $80.32 → $69.18
Next anchor: T+60d in 6w
Latest observation: T+28 -25.26% FF3 residual α
Entry anchored
Aug 18, 2026
via day open
T+1d
-1.84%
call -1.84% · α -1.00%
$78.84
settled 6w ago
T+5d
+2.93%
call +2.93% · α +3.31%
$82.67
settled 5w ago
T+20d
-13.87%
call -13.87% · α -11.92%
$69.18
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

CEO John Quisel and COO Jonathan Yu sold a combined $723K in open-market shares following derivative exercises. The CEO's sales ($656K) represent the bulk of the cluster and occurred on the same day as a large option exercise, suggesting a tax-planning or liquidity-driven disposition rather than a bearish signal. The total value is ~0.02% of IRON's $3.1B market cap, well below the 0.1% materiality threshold, making this a routine insider transaction cluster with no actionable directional signal.

Key Financial Metrics

Direction
selling
Total Value
$723.0K
Insiders
2

Key Facts

  • CEO Quisel sold 8,400 shares at $78.11 for $656K on 2026-08-17
  • COO Yu sold 804 shares at $82.64 for $66K on 2026-08-12
  • Both sales followed derivative exercises (Quisel exercised 33,000 options at $13.50 and $0; Yu exercised 804 options at $13.50 and $0)
  • Total open-market sales: $723K, representing ~0.02% of $3.1B market cap
  • No open-market purchases in the cluster

Financial Impact

Total insider sales of $723K, ~0.02% of market cap — immaterial

insider ownership

Risk Factors

  • CEO sold at $78.11, near recent highs — could indicate personal portfolio rebalancing
  • No insider buying to offset sales, but the dollar amount is too small to be informative

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IRON-1787094080022
20 reports for IRON
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+60▲ +17.13%Jun 9, 2026
Filters
Rows
Reports for IRON — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
8-K
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 9, 2026
22d ago
Press Release
BULLISH ★ 7/10
$74.14 $69.18▼ −6.69%▼ −6.19%$64.48 (−13.03%)
Sep 3, 2026
28d ago
Insider Cluster
BEARISH ★ 5/10
$79.23 $68.92▲ +13.01%▲ +11.80%$64.48 (+18.62%)
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$79.37 $70.06▼ −11.73%▼ −10.58%$64.48 (−18.76%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$82.55 $79.37▼ −3.85%▼ −4.12%$64.48 (−21.89%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.32 $82.67▲ +2.93%▲ +3.31%$64.48 (−19.72%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.05 $80.94▲ +1.11%▲ +2.30%$64.48 (−19.45%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 30, 2026
9w ago
Press Release
BULLISH ★ 7/10
$79.21 $77.44▼ −2.23%▼ −5.86%$64.48 (−18.60%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$76.02 $74.32▼ −2.24%▼ −1.26%$64.48 (−15.18%)
Showing 10 of 20

US Market Status

Market Open — Closes in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 18, 2026